J Cell Biochem. 2021 Nov;122 Suppl 1:S33. doi: 10.1002/jcb.29992. Epub 2021 Jun 8.
Retraction: "Long noncoding RNA TALNEC2 plays an oncogenic role in breast cancer by binding to EZH2 to target p57 and involving in p-p38 MAPK and NF-κB pathways," by Enqi Qiao, Daobao Chen, Qinglin Li, Weiliang Feng, Xingfei Yu, Xiping Zhang, Liang Xia, Ju Jin, Hongjian Yang, J Cell Biochem. 2019; 3978-3988: The above article, published online on 30 October 2018 in Wiley Online Library (https://onlinelibrary.wiley.com/doi/abs/10.1002/jcb.27680), has been retracted by agreement between the the journal's Editor in Chief, Prof. Dr. Christian Behl, and Wiley Periodicals LLC. The retraction has been agreed following an investigation based on allegations raised by a third party. Several flaws and inconsistencies between results presented and experimental methods described were found, the editors consider the conclusions of this article to be invalid. The authors collaborated in the investigation initially, but were not available for a final confirmation of the retraction.
乔恩奇、陈道宝、李庆林、冯伟良、于星飞、张喜平、夏亮、金菊、杨宏建所著的“长链非编码RNA TALNEC2通过与EZH2结合靶向p57并参与p-p38 MAPK和NF-κB信号通路在乳腺癌中发挥致癌作用”,发表于《细胞生物化学杂志》2019年第3978 - 3988页。上述文章于2018年10月30日在线发表于威利在线图书馆(https://onlinelibrary.wiley.com/doi/abs/10.1002/jcb.27680),经该期刊主编克里斯蒂安·贝尔教授与威利期刊有限责任公司协商一致后予以撤稿。此次撤稿是在基于第三方提出的指控进行调查之后达成的。发现所呈现的结果与所描述的实验方法之间存在若干缺陷和不一致之处,编辑们认为本文的结论无效。作者最初参与了调查,但无法对撤稿进行最终确认。